Recognizing the extraordinary resilience and courage of children and families fighting neuroblastoma and supports the incredible effort of clinicians and researchers working to address this disease and expressing support for September 3, 2026, to be designated as "Neuroblastoma Awareness Day".
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
This resolution recognizes the strength and courage of children and families battling neuroblastoma, a rare childhood cancer. It also acknowledges the dedication of clinicians and researchers working to find better treatments and improve outcomes. The resolution proposes designating September 3rd of each year as ‘Neuroblastoma Awareness Day’ to raise awareness and support continued research efforts.
Key provisions
- Designates September 3, 2026, as Neuroblastoma Awareness Day.
- Recognizes the challenges faced by children and families with neuroblastoma.
- Acknowledges the significant impact of neuroblastoma on childhood cancer mortality.
- Highlights the need for increased research funding for pediatric cancers.
- Recognizes advancements in treatment, such as anti-GD2 immunotherapy and CAR-T cell therapies.
Who is affected
- Children with neuroblastoma
- Families of children with neuroblastoma
- Clinicians and researchers involved in neuroblastoma treatment and research
- Pediatric cancer patients and their families
Notable changes
- Establishes a dedicated awareness day to support the neuroblastoma community.
- Calls for increased investment in pediatric cancer research.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
1 on record
Primary sponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours